BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11135089)

  • 1. Long-term reduction of plasma homocysteine levels by super-flux dialyzers in hemodialysis patients.
    Van Tellingen A; Grooteman MP; Bartels PC; Van Limbeek J; Van Guldener C; Wee PM; Nubé MJ
    Kidney Int; 2001 Jan; 59(1):342-7. PubMed ID: 11135089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
    Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
    Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels.
    Galli F; Benedetti S; Buoncristiani U; Piroddi M; Conte C; Canestrari F; Buoncristiani E; Floridi A
    Kidney Int; 2003 Aug; 64(2):748-55. PubMed ID: 12846775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced long-term reduction of plasma leptin concentrations by super-flux polysulfone dialysers.
    van Tellingen A; Grooteman MP; Schoorl M; ter Wee PM; Bartels PC; Schoorl M; van der Ploeg T; Nubé MJ
    Nephrol Dial Transplant; 2004 May; 19(5):1198-203. PubMed ID: 14993491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
    Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
    Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of long-term intravenous high dose B-complex vitamins with or without folic acid on serum homocysteine in hemodialysis patients.
    Sombolos K; Fragia T; Natse T; Bartholomatos G; Karagianni A; Katsaris G; Christidou F; Bamichas G; Stangou M; Papagalanis N
    J Nephrol; 2002; 15(6):671-5. PubMed ID: 12495282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
    Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
    J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine supplementation does not decrease total plasma homocysteine in chronic hemodialysis patients.
    Taes YE; Delanghe JR; De Bacquer D; Langlois M; Stevens L; Geerolf I; Lameire NH; De Vriese AS
    Kidney Int; 2004 Dec; 66(6):2422-8. PubMed ID: 15569335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total serum homocysteine, folate and vitamin B12 in a Greek school age population.
    Papandreou D; Mavromichalis I; Makedou A; Rousso I; Arvanitidou M
    Clin Nutr; 2006 Oct; 25(5):797-802. PubMed ID: 16690175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The postdialytic rise in the plasma total homocysteine concentration is delayed.
    Arnadottir M; Wingren K; Hultberg B; Hegbrant J
    Blood Purif; 2002; 20(4):334-7. PubMed ID: 12169841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
    Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Bagley P; Massy ZA; Jacques PF; Dworkin L; Selhub J
    Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of methylcobalamin and folate effects on homocysteine in hemodialysis patients.
    Trimarchi H; Schiel A; Freixas E; Díaz M
    Nephron; 2002 May; 91(1):58-63. PubMed ID: 12021520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
    Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
    Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of folate and vitamin B12 in lowering homocysteine concentrations in hemodialysis patients.
    Azadibakhsh N; Hosseini RS; Atabak S; Nateghiyan N; Golestan B; Rad AH
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):779-88. PubMed ID: 19736473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
    Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
    Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dialyser membrane pore size on plasma homocysteine levels in haemodialysis patients.
    De Vriese AS; Langlois M; Bernard D; Geerolf I; Stevens L; Boelaert JR; Schurgers M; Matthys E
    Nephrol Dial Transplant; 2003 Dec; 18(12):2596-600. PubMed ID: 14605283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum homocysteine and folate but not vitamin B12 are predictors of CHD mortality in older adults.
    Gopinath B; Flood VM; Rochtchina E; Thiagalingam A; Mitchell P
    Eur J Prev Cardiol; 2012 Dec; 19(6):1420-9. PubMed ID: 21960652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine, vitamin B12, serum and erythrocyte folate in peritoneal dialysis patients.
    De Vecchi AF; Bamonti-Catena F; Finazzi S; Patrosso C; Taioli E; Novembrino C; Colucci P; Lando G; De Franceschi M; Marocchi A; Maiolo AT
    Clin Nephrol; 2001 Apr; 55(4):313-7. PubMed ID: 11334318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous folinic acid and vitamin B12 supplementation and homocysteine concentration in hemodialysis patients].
    Corghi E; Patrosso C; Bamonti F; Baragetti I; Novembrino C; Lando G; De Franceschi M; Buccianti G
    G Ital Nefrol; 2002; 19(3):301-7. PubMed ID: 12195398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.